Dr. Mark Liebling, Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 166 Kinsley St Ste 301, Nashua, NH 03060 Phone: 603-883-5673 Fax: 603-689-1343 |
Ajay K Sharma, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-577-2039 Fax: 603-882-5656 |
Dr. Craig Berry, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 166 Kinsley St Ste 301, Nashua, NH 03060 Phone: 603-883-5673 Fax: 603-689-1343 |
Dr. Richard M Hayes, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2300 Southwood Dr, Nashua, NH 03063 Phone: 603-577-4021 |
Steven Beaudette, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 166 Kinsley St Ste 301, Nashua, NH 03060 Phone: 603-883-5673 |
Dr. Peter Klementowicz, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 166 Kinsley St, Ste 301, Nashua, NH 03060 Phone: 603-883-5673 |
Dr. Steven L Schwartz, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-577-2039 Fax: 603-882-5656 |
Yuka Endo, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St # 1184, Nashua, NH 03060 Phone: 603-577-2039 Fax: 603-882-5656 |
Dr. Wendi Cardeiro, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-577-2039 Fax: 603-882-5656 |
News Archive
The influenza A virus is a contagious and severe respiratory infection that affects animals but also humans. Researchers from the University of Barcelona have synthetized some molecules which are able to block the virus that causes influenza A and some of the mutations that make it resistant to common drugs.
Intercept Pharmaceuticals, Inc. (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, such as primary biliary cirrhosis, today reported financial results for the quarter and six months ended June 30, 2013 and announced presentations at an upcoming medical conference and upcoming investor conferences.
Recent scientific advances and increased vaccine manufacturing capacity have prompted experts to increase their projections of how many pandemic influenza vaccine courses can be made available in the coming years.
Scientific researchers have turned folklore on its head by showing that alcohol consumption by women who are breast feeding reduces their milk supply, rather than boosting it.
› Verified 7 days ago